<DOC>
	<DOCNO>NCT01082055</DOCNO>
	<brief_summary>Antiarrhythmic drug associate significant side effect profile . Amiodarone primarily class III action whilst unrivalled efficacy management certain arrhythmia , formidable side effect profile . Complications continue therapy include , thyroiditis , hepatitis , cholestasis , increase skin sensitivity pulmonary fibrosis . Current prescribe guideline recommend frequent blood test monitor kidney , liver thyroid function , addition frequent pulmonary function test . Sotalol betablocker possess class III action high dos may predispose QT prolongation Other class I agent flecainide propafenone associate sudden cardiac death certain population , may predispose arrhythmia . This study examine incidence discontinuation AAD therapy adverse event .</brief_summary>
	<brief_title>Antiarrythmic Drugs - Long-term Follow-up Modern Era</brief_title>
	<detailed_description />
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>At least one prescription antiarrythmic drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Cardiac</keyword>
	<keyword>Dysrhythmia</keyword>
	<keyword>Safety</keyword>
</DOC>